AtherosclerosisNCT00556101
Patient Acceptance of Whole Body Magnetic Resonance Angiography
An observational study of Atherosclerosis and Intermittent Claudication, run by Copenhagen University Hospital at Herlev at 1 site in Denmark.
Trial summary
Investigation of how the patients experience whole body MRA. After the WB-MRA the patients will fill in a questionnaire, that contains questions about the WB-MRA procedure and how the patient felt during the examination. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Atherosclerosis, Intermittent Claudication, MRI
- What is being tested?
- Whole body magnetic resonance angiography
- Type of treatment
- Surgery or procedure
- How many people
- 81 participants
- Where
- 1 siteDenmark
- Study dates
- Nov 2007to Jul 2009
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: Patients with pheripheral arterial disease
Who may be able to join
- Symptomatic lower extremity ischemia (claudication, ischemic wounds)
- Referred to digital subtraction angiography (DSA)
Who cannot join
- Renal insufficiency (GFR < 30 ml/min)
- Contra-indications for MRI-examination (claustrophobia, metal-implants, pacemaker)
- Dementia
- Pregnancy/lactation
- Allergy to gadolinium based MRI contrast agents
- Acute disease
Trial locations and contacts
1 site in 1 country.
Denmark1 site
Department of Radiology, Herlev University Hospital
Herlev Copenhagen, Herlev, DK2730
About this study
Official title: Whole Body Magnetic Resonance Angiography: Questionnaire Examination of Patient Acceptance.
Investigation of how the patients experience whole body MRA. After the WB-MRA the patients will fill in a questionnaire, that contains questions about the WB-MRA procedure and how the patient felt during the examination.
We expect that the patients will report a high degree of satisfaction with the WB-MRA procedure, with little discomfort.
Read the detailed description
WB-MRA is performed in patients referred for conventional x-ray based angiography. The WB-MRA is performed first in all patients.
After both examinations are completed the patients will be asked to fill in a questionnaire containing questions about their experience of the 2 procedures.
We will then compare the results for the procedures.
- Conditions
- Atherosclerosis, Intermittent Claudication, MRI
- Being tested
- Whole body magnetic resonance angiography
- Keywords
- Magnetic resonance, whole body, angiography, questionnaire
- Medical subject headings
- Atherosclerosis, Intermittent Claudication
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Whole body magnetic resonance angiographyProcedure or surgery
What is being measured
The primary outcome is the main question the study is designed to answer.
Patient acceptance of Whole body MRA
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted9 Nov 2007 (estimated)
- Study startNov 2007
- Study completionJul 2009
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for AtherosclerosisStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Time perspective
- Prospective
- Enrolment
- 81 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Copenhagen University Hospital at Herlev
- Sponsor type
- University, hospital or other
- Collaborators
- Copenhagen University Hospital, Rigshospitalet
- Investigators
- Henrik S Thomsen, Prof. MD., Study chair, University Hospital at Herlev Copenhagen Denmark
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT00556101
- Sponsor's protocol ID
- WB-angio herlev 4
- Status last verified
- Aug 2009
- First submitted
- 8 Nov 2007
- Last updated
- 19 Aug 2009
- Results posted
- No
- Data monitoring committee
- Yes
Study at a glance
From the registry record, last updated by the sponsor on 19 Aug 2009. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Whole Body Magnetic Resonance Angiography: Questionnaire Examination of Patient Acceptance.
- ClinicalTrials.gov ID
- NCT00556101
- Acronym / sponsor ID
- WB-angio herlev 4
- Conditions
- Atherosclerosis, Intermittent Claudication, MRI
- Keywords
- Magnetic resonance, whole body, angiography, questionnaire
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 81 participants (estimated)
- Lead sponsor
- Copenhagen University Hospital at HerlevUniversity, hospital or other
- Collaborators
- Copenhagen University Hospital, Rigshospitalet
- Study start
- Nov 2007
- Study completion
- Jul 2009 (actual)
- First posted
- 9 Nov 2007 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Investigation of how the patients experience whole body MRA. After the WB-MRA the patients will fill in a questionnaire, that contains questions about the WB-MRA procedure and how the patient felt during the examination.
We expect that the patients will report a high degree of satisfaction with the WB-MRA procedure, with little discomfort.
Detailed description
WB-MRA is performed in patients referred for conventional x-ray based angiography. The WB-MRA is performed first in all patients.
After both examinations are completed the patients will be asked to fill in a questionnaire containing questions about their experience of the 2 procedures.
We will then compare the results for the procedures.
Study design
- Time perspective
- Prospective
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- Patients with pheripheral arterial disease
Key inclusion criteria (2 listed)
- Symptomatic lower extremity ischemia (claudication, ischemic wounds)
- Referred to digital subtraction angiography (DSA)
Key exclusion criteria (6 listed)
- Renal insufficiency (GFR < 30 ml/min)
- Contra-indications for MRI-examination (claustrophobia, metal-implants, pacemaker)
- Dementia
- Pregnancy/lactation
- Allergy to gadolinium based MRI contrast agents
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Whole body magnetic resonance angiography | Procedure or surgery | – |
Primary outcome
Patient acceptance of Whole body MRA
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 19 Aug 2009.
Related trials for Atherosclerosis
Active, not recruitingPhase 4
Effects of Sequential Therapy With Mexidol® (Intravenous) and Mexidol® FORTE 250 (Oral) on Functional Brain Activity Assessed by Functional Magnetic Resonance Imaging and Biochemical Parameters in Patients With Chronic Cerebral Ischemia: A Comparison of Patients With and Without Metabolic Disorders
Metabolic Abnormalities, Obesity & Overweight
Active, not recruiting
SUCCESS (SelUtion, Safety, effiCaCy, hEalth economicS and promS) PTA Study
Peripheral Artery Disease
Active, not recruitingPhase 3
A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients.
Primary Prevention of Atherosclerotic Cardiovascular Disease
RecruitingPhase 3
Reducing Adverse Vascular Outcomes With Factor XI Inhibition in Adult Participants With Peripheral Artery Disease
Peripheral Artery Disease (PAD)
Recruiting
The THOR IDE Study
Peripheral Artery Disease, Peripheral Artery Stenosis
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Henrik S Thomsen, Prof. MD. study chair
University Hospital at Herlev Copenhagen Denmark
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Atherosclerosis and Intermittent Claudication, run by Copenhagen University Hospital at Herlev at 1 site in Denmark.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 19 Aug 2009. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Denmark. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Patient acceptance of Whole body MRA. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 19 Aug 2009.